Related Experiment Video
Updated: Feb 15, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
Co-existing infantile hepatic hemangioma and mesenchymal hamartoma in a neonate
Nicolas Berte1, Alya Filfilan1, Laurence Mainard2
1Department of Pediatric Surgery, CHRU Nancy, 54500 Vandoeuvre-lès-Nancy, France.
Insights
This case report details a newborn with infantile hepatic hemangioma (IHH) and mesenchymal hamartoma (MH), experiencing severe complications. Successful treatment involved surgery and beta-blockers, leading to a full recovery.
Area of Science:
- Pediatric Oncology
- Hepatology
- Surgical Pathology
Background:
- Infantile hepatic hemangioma (IHH) and mesenchymal hamartoma (MH) are the most common pediatric liver tumors.
- Early diagnosis and management are crucial for favorable outcomes in affected newborns.
Observation:
- A newborn presented with a rapidly growing liver mass, anemia, respiratory, and renal failure.
- Imaging revealed multifocal cystic and solid liver lesions with arterial enhancement.
- Elevated alpha-fetoprotein levels were noted in the absence of cardiac or cutaneous signs.
Findings:
- Pathological analysis confirmed synchronous IHH (GLUT-1 positive) and MH.
- Initial non-anatomical liver resection was followed by further surgical interventions for persistent lesions.
- Combined surgical and medical treatment (beta-blockers) led to lesion resolution.
Implications:
- This case highlights the importance of prompt diagnosis and multidisciplinary management for complex pediatric liver tumors.
- The successful use of beta-blockers suggests a potential role in managing refractory or complex cases of IHH and MH.
- Synchronous occurrence of IHH and MH, though rare, requires careful consideration in the differential diagnosis of neonatal liver masses.
Abstract:
Infantile hepatic hemangioma (IHH) and mesenchymal hamartoma (MH) form the first and second most common benign hepatic tumors in children. In this case report, we present a newborn child in whom a growing hepatic mass was discovered at the age of 7 days. She suffered also from anemia, respiratory and renal failure. No signs of heart disease or cutaneous lesions were detected. Alpha-fetoprotein was elevated for her age (3562.2 ng/ml). Imaging studies showed multifocal large cystic lesions associated with heterogeneous small solid lesions with arterial enhancement of the liver. Non-anatomical liver resection was performed initially and synchronous MH and IHH GLUT-1 positive were discovered in the pathological analysis. Segmental IV hepatic resection and later on selective cysts excision were done for persistent hepatic lesion despite medical treatment. After 14 months of beta-blockers treatment, clinical follow-up shows a healthy child with no residual cystic lesions.
More Related Videos
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Mesenchymal Stem Cells
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters